Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of multiple doses of PF-02545920 subjects with
schizophrenia or schizo-affective disorder who are currently clinically stable and to
evaluate the serum and urine pharmacokinetics of PF-02545920 and the N-desmethyl metabolite,
PF-01001252, after multiple doses of PF-02545920 administered orally.